Verity & Verity’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $31.5M | Sell |
283,778
-43,792
| -13% | -$4.86M | 2.7% | 6 |
|
2025
Q1 | $36.7M | Sell |
327,570
-50,532
| -13% | -$5.66M | 3.22% | 1 |
|
2024
Q4 | $34.9M | Buy |
378,102
+10,771
| +3% | +$995K | 3.19% | 2 |
|
2024
Q3 | $30.8M | Buy |
367,331
+2,250
| +0.6% | +$189K | 3.02% | 3 |
|
2024
Q2 | $25M | Buy |
365,081
+36,263
| +11% | +$2.49M | 2.73% | 8 |
|
2024
Q1 | $24.1M | Sell |
328,818
-13,728
| -4% | -$1.01M | 2.68% | 6 |
|
2023
Q4 | $27.7M | Buy |
342,546
+1,239
| +0.4% | +$100K | 3.18% | 3 |
|
2023
Q3 | $25.6M | Buy |
341,307
+4,131
| +1% | +$310K | 3.2% | 2 |
|
2023
Q2 | $26M | Buy |
337,176
+17,453
| +5% | +$1.35M | 3.19% | 5 |
|
2023
Q1 | $26.5M | Buy |
319,723
+3,706
| +1% | +$307K | 3.39% | 1 |
|
2022
Q4 | $27.1M | Sell |
316,017
-3,580
| -1% | -$307K | 3.54% | 1 |
|
2022
Q3 | $19.7M | Buy |
319,597
+9,959
| +3% | +$614K | 3.17% | 1 |
|
2022
Q2 | $19.1M | Sell |
309,638
-3,003
| -1% | -$186K | 2.93% | 3 |
|
2022
Q1 | $18.6M | Buy |
312,641
+102,665
| +49% | +$6.1M | 2.58% | 6 |
|
2021
Q4 | $15.2M | Buy |
209,976
+5,053
| +2% | +$367K | 2.18% | 12 |
|
2021
Q3 | $13.8M | Buy |
204,923
+9,032
| +5% | +$609K | 2.07% | 14 |
|
2021
Q2 | $13.5M | Hold |
195,891
| – | – | 2.13% | 10 |
|
2021
Q1 | $13M | Buy |
195,891
+43,431
| +28% | +$2.89M | 2.11% | 11 |
|
2020
Q4 | $9.53M | Buy |
152,460
+19,497
| +15% | +$1.22M | 1.8% | 20 |
|
2020
Q3 | $8.46M | Buy |
132,963
+38,200
| +40% | +$2.43M | 1.86% | 17 |
|
2020
Q2 | $7.27M | Buy |
94,763
+1,992
| +2% | +$153K | 1.73% | 25 |
|
2020
Q1 | $6.94M | Buy |
92,771
+32,490
| +54% | +$2.43M | 1.95% | 18 |
|
2019
Q4 | $3.92M | Buy |
60,281
+35,721
| +145% | +$2.32M | 0.76% | 51 |
|
2019
Q3 | $1.52M | Buy |
+24,560
| New | +$1.52M | 0.32% | 77 |
|